Skip to main
IMAX

IMAX (IMAX) Stock Forecast & Price Target

IMAX (IMAX) Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 45%
Buy 36%
Hold 18%
Sell 0%
Strong Sell 0%

Bulls say

Imax is a strong contender in the entertainment industry, with their technology platform, diversified content portfolio, global reach, and potential for expansion. While they have had a successful year with high box office numbers, their reliance on blockbuster films and potential industry struggles may pose challenges and impact their stock value, which is currently undervalued at a target price of $47. Their recent success with "The Odyssey" and upcoming releases like "Dune: Part 3" showcases their potential for growth and serves as a blueprint for other filmmakers and studios to utilize IMAX technology, further solidifying their position in the market.

Bears say

Imax is facing significant risks in its largest market, China, as any changes in regulations or behaviors that impede the success of Hollywood content could impact the company's financial performance. While the company has a solid track record with local films, it still depends on the distribution of Hollywood content in China. The recent success of The Odyssey highlights the potential for IMAX to garner outsized returns, but it remains to be seen if this can be consistently replicated. These uncertainties, coupled with high valuation multiples, lead to a negative outlook on the stock.

IMAX (IMAX) has been analyzed by 11 analysts, with a consensus rating of Buy. 45% of analysts recommend a Strong Buy, 36% recommend Buy, 18% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of IMAX and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About IMAX (IMAX) Forecast

Analysts have given IMAX (IMAX) a Buy based on their latest research and market trends.

According to 11 analysts, IMAX (IMAX) has a Buy consensus rating as of Aug 29, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $51.27, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $51.27, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

IMAX (IMAX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.